Organogenesis Holdings
ORGO
27 hedge funds and large institutions have $259M invested in Organogenesis Holdings in 2017 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 10 increasing their positions, 2 reducing their positions, and 5 closing their positions.
400% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 2
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
21% more capital invested
Capital invested by funds: $214M → $259M (+$44.8M)
4% less funds holding
Funds holding: 28 → 27 (-1)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$23.7M |
| 2 |
AGC
Angelo Gordon & Co
New York
|
+$18.6M |
| 3 |
WCMNY
Westchester Capital Management (New York)
Valhalla,
New York
|
+$9.93M |
| 4 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
+$3.96M |
| 5 |
ACPU
Arrowgrass Capital Partners (US)
Dover,
Delaware
|
+$2.91M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
Assured Investment Management
New York
|
-$23.9M |
| 2 |
HIM
HGC Investment Management
Toronto,
Ontario, Canada
|
-$2.37M |
| 3 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
-$2M |
| 4 |
LIM
Longfellow Investment Management
Boston,
Massachusetts
|
-$1.25M |
| 5 |
ICM
Ionic Capital Management
New York
|
-$1.06M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TRCT
26
Tower Research Capital (TRC)
New York
| $20K | +$8.46K | +852 | +72% |
|
27
Morgan Stanley
New York
| $2K | +$2.01K | +202 | New |
|
|
AIM
28
Assured Investment Management
New York
| – | -$23.9M | -2,386,808 | Closed |
|
|
AA
29
AQR Arbitrage
Greenwich,
Connecticut
| – | -$2M | -200,000 | Closed |
|
|
ICM
30
Ionic Capital Management
New York
| – | -$1.06M | -106,056 | Closed |
|
31
Hudson Bay Capital Management
Stamford,
Connecticut
| – | -$309K | -30,890 | Closed |
|
32
UBS Group
Zurich,
Switzerland
| – | -$5K | -500 | Closed |
|
ORGO Hedge Fund Activity: Q4 2017 in Review
27 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Organogenesis Holdings (ORGO) for Q4 2017, worth a combined $259M — up 21% from $214M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of ORGO and 4 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 10 added.
The largest buyer was ArrowMark Colorado Holdings, opening a new position worth an estimated $23.7M. The largest seller was Assured Investment Management, exiting entirely with an estimated $23.9M sold.
- 27 institutional investors held Organogenesis Holdings (ORGO) as of Q4 2017, down from 28 in Q3 2017.
- Funds reported $259M of Organogenesis Holdings stock for Q4 2017, up 21% quarter-over-quarter.
- 4 funds opened new Organogenesis Holdings positions in Q4 2017 and 5 closed out, a net change of -1 holder.
- The largest Organogenesis Holdings buyer in Q4 2017 was ArrowMark Colorado Holdings, an estimated $23.7M added.
- The largest Organogenesis Holdings seller in Q4 2017 was Assured Investment Management, an estimated $23.9M sold.
Based on aggregated 13F filings for Q4 2017.